Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumour disease

被引：0
|
作者：
Grabowski, P [1 ]
Griss, S [1 ]
Arnold, CN [1 ]
Hoersch, D [1 ]
Göke, R [1 ]
Arnold, R [1 ]
Heine, B [1 ]
Stein, H [1 ]
Zeitz, M [1 ]
Scheruebl, H [1 ]
机构：
[1] Hosp Dept Gastroenterol, Berlin, Germany
来源：
EUROPEAN JOURNAL OF ENDOCRINOLOGY | 2005年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Stress hyperglycemia ratio: a novel prognostic marker in chronic kidney disease
    Chen, Tianquan
    Zhu, Yijiao
    Liu, Yushuang
    Li, Hongxia
    Han, Zhe
    Liu, Min
    Xu, Xia
    Wang, Rong
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01):
  • [42] A novel somatostatin-derived optical/nuclear probe: preclinical evaluation in vitro and in neuroendocrine tumour xenografts
    Santini, C.
    Kuil, J.
    Bunschoten, A.
    Ridwan, Y. R. Y.
    Essers, J.
    Bernsen, M.
    Leeuwen, F. F. W. B.
    De Jong, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S264 - S264
  • [43] Prothrombin activity is a novel and powerful prognostic marker in patients not taking oral anticoagulants with acutely decompensated heart failure
    Okada, A.
    Sugano, Y.
    Nagai, T.
    Shibata, T.
    Nakamura, K.
    Kusano, K. F.
    Ishihara, M.
    Ogawa, H.
    Yasuda, S.
    Anzai, T.
    EUROPEAN HEART JOURNAL, 2014, 35 : 676 - 677
  • [44] Loss of Nuclear p27 Expression and Its Prognostic Role in Relation to Cyclin E and p53 Mutation in Gastroenteropancreatic Neuroendocrine Tumors
    Grabowski, Patricia
    Schrader, Joerg
    Wagner, Julia
    Hoersch, Dieter
    Arnold, Rudolf
    Arnold, Christian N.
    Georgieva, Inna
    Stein, Harald
    Zeitz, Martin
    Daniel, Peter T.
    Sturm, Isrid
    CLINICAL CANCER RESEARCH, 2008, 14 (22) : 7378 - 7384
  • [45] INSM1, A Novel Nuclear Marker of Neuroendocrine Neoplasms, Can be Applied to Lung Cytology Specimens
    Doxtader, Erika
    Mukhopadhyay, Sanjay
    MODERN PATHOLOGY, 2018, 31 : 139 - 139
  • [46] INSM1, A Novel Nuclear Marker of Neuroendocrine Neoplasms, Can be Applied to Lung Cytology Specimens
    Doxtader, Erika
    Mukhopadhyay, Sanjay
    LABORATORY INVESTIGATION, 2018, 98 : 139 - 139
  • [47] Insulinoma-associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma)
    Rush, Patrick S.
    Rosenbaum, Jason N.
    Roy, Madhuchhanda
    Baus, Rebecca M.
    Bennett, Daniel D.
    Lloyd, Ricardo V.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2018, 45 (02) : 129 - 135
  • [48] A novel tumour marker RCAS1 in a case of extramammary Paget's disease
    Enjoji, M
    Noguchi, K
    Watanabe, H
    Yoshida, Y
    Kotoh, K
    Nakashima, M
    Watanabe, T
    Nakamuta, M
    Nawata, H
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 (02) : 211 - 213
  • [49] IDENTIFICATION OF SGK1 AS A NOVEL PROGNOSTIC MARKER FOR DISEASE OUTCOME IN MEDULLOBLASTOMA
    Sturm, Dominik
    Remke, Marc
    Pleier, Sabrina
    Witt, Hendrik
    Reifenberger, Guido
    Felsberg, Joerg
    Kulozik, Andreas E.
    Korshunov, Andrey
    Lichter, Peter
    Pfister, Stefan
    NEURO-ONCOLOGY, 2009, 11 (05) : 651 - 652
  • [50] Placental weight as a novel prognostic marker for neonatal survival in congenital heart disease
    Toscano, Marika
    Westen, Elizabeth
    Laniewski, Stephanie
    Malshe, Amol
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S271 - S271
12345